# Neuralink Launches GB-PRIME Brain-Chip Clinical Trial in Great Britain

> clinical trial · REPORTED · 2025-07-31

Neuralink received regulatory approvals from the MHRA, Health Research Authority, and a UK ethics committee to launch GB-PRIME, its first clinical study in Great Britain, across two NHS sites — University College London Hospitals and Newcastle upon Tyne Hospitals. The study will enrol up to seven participants with severe paralysis to evaluate the safety and initial functionality of its fully implantable N1 brain-computer interface.

About Neuralink: Neuralink develops fully implantable brain-computer interfaces (BCIs) designed to enable people with severe paralysis or neurological disorders to control digital devices and communicate using only their thoughts.

- Company: Neuralink
- Sector: medical_device
- Primary source: https://neuralink.com/updates/gb-prime-study-launch/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.